GENERAL AMERICAN INVESTORS CO INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GENERAL AMERICAN INVESTORS CO INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$1,080,000
-81.9%
600,000
-15.8%
0.12%
-83.5%
Q2 2020$5,977,000
+60.1%
712,4000.0%0.76%
+50.1%
Q1 2020$3,733,000
+8.1%
712,400
+12.7%
0.50%
+59.8%
Q4 2019$3,453,000
+27.2%
632,400
+13.5%
0.32%
+17.9%
Q3 2019$2,715,000
-29.7%
557,4000.0%0.27%
-26.8%
Q2 2019$3,863,000
-0.3%
557,4000.0%0.37%
-4.7%
Q1 2019$3,874,000557,4000.38%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders